Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia
Goscé L, Tadesse A, Foster N, van Kalmthout K, van Rest J, van der Wal J, Harker M, Madden N, Abdurhman T, Gadissa D, Bedru A, Dube T, Alacapa J, Mganga A, Deyanova N, Charalambous S, Letta T, Jerene D, White R, Fielding K, Houben R, McQuaid C. Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia. BMJ Global Health 2024, 9: e016997. PMID: 39653521, PMCID: PMC11628985, DOI: 10.1136/bmjgh-2024-016997.Peer-Reviewed Original ResearchConceptsDigital adherence technologiesHealthcare providersTB deathsPatient cost savingsStandard of careAdherence technologiesLabelling interventionsEpidemiological impactASCENT trialDifferentiated careMedication labelsIncident TBImprove tuberculosisProvider costsTB incidenceCareTB episodeProvidersCompartmental transmission modelPotential long-termCost of treatmentInterventionTreatment completionHealthcareEpidemiological benefits
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply